M
Marc Rott
Researcher at University of Wisconsin–La Crosse
Publications - 11
Citations - 186
Marc Rott is an academic researcher from University of Wisconsin–La Crosse. The author has contributed to research in topics: Antibacterial agent & Lanostane. The author has an hindex of 7, co-authored 11 publications receiving 171 citations.
Papers
More filters
Journal ArticleDOI
Antibacterial Compounds from Mushrooms II: Lanostane Triterpenoids and an Ergostane Steroid with Activity Against Bacillus cereus Isolated from Fomitopsis pinicola
TL;DR: Anti- Bacillus cereus bioassay-guided fractionation of a crude extract of the American mushroom, Fomitopsis pinicola, was performed using thin-layer Chromatography, Sephadex LH-20 column chromatography, and preparative-scale HPLC to test for antibacterial activity against B. cereus.
Journal ArticleDOI
Antibacterial Compounds from Mushrooms I: A Lanostane-Type Triterpene and Prenylphenol Derivatives from Jahnoporus hirtus and Albatrellus flettii and Their Activities Against Bacillus cereus and Enterococcus faecalis
TL;DR: One novel compound and three others were shown to possess antimicrobial activities against these gram-positive bacteria employed as surrogates for more virulent and dangerous pathogens.
Journal ArticleDOI
New classes of Gram-positive selective antibacterials: inhibitors of MRSA and surrogates of the causative agents of anthrax and tuberculosis.
M. Shahjahan Kabir,Kathleen C. Engelbrecht,Rebecca Polanowski,Sarah M. Krueger,Rachel Ignasiak,Marc Rott,William R. Schwan,Mary E. Stemper,Kurt D. Reed,David R. Sherman,James M. Cook,Aaron Monte +11 more
TL;DR: Preliminary structure–activity relationship studies indicated that both new classes of synthetic analogs, as well as the stilbenes, show promising activity against Gram-positive bacteria when at least one phenolic moiety is present, but not when absent.
Journal ArticleDOI
A new class of potential anti-tuberculosis agents: Synthesis and preliminary evaluation of novel acrylic acid ethyl ester derivatives.
M. Shahjahan Kabir,Ojas A. Namjoshi,Ranjit Verma,Rebecca Polanowski,Sarah M. Krueger,David R. Sherman,Marc Rott,William R. Schwan,Aaron Monte,James M. Cook +9 more
TL;DR: Minimum inhibitory concentration assays indicated that two of these compounds have greater in vitro activity against Mycobacterium smegmatis than rifampin, one of the current, first-line anti-mycobacterial chemotherapeutic agents.
Journal ArticleDOI
Antibacterial Spirobisnaphthalenes from the North American Cup Fungus Urnula craterium
Xueting Liu,William R. Schwan,Thomas J. Volk,Marc Rott,Miaomiao Liu,Pei Huang,Zhong Liu,Ying Wang,Nicholas C. Zitomer,Cassandra Sleger,Scott C. Hartsel,Aaron Monte,Lixin Zhang +12 more
TL;DR: Urnucratin A (1) was found to be active against methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and Streptococcus pyogenes with MIC values of 2, 1, and 0.5 μg/mL, respectively.